Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: An exploratory, hypothesis-generating study

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 3, 2014, Pages 244-249

  Glueck, Charles J ^a   Richardson Royer, Caitlin ^a   Schultz, Reiker ^a   Burger, Tim ^a   Bowe, Dedrick ^a   Padda, Jagjit ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

blood coagulation factors; clinical epidemiology; clinical thrombophilia; deep venous thrombosis; endocrinology; hypercoagulability

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FIBRINOLYSIS; HOSPITALIZATION; HUMAN; HYPOFIBRINOLYSIS; HYPOTHESIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PREVALENCE; PRIORITY JOURNAL; THROMBOGENICITY; THROMBOPHILIA; VERY ELDERLY;

BLOOD COAGULATION FACTORS; CLINICAL EPIDEMIOLOGY; CLINICAL THROMBOPHILIA; DEEP VENOUS THROMBOSIS; ENDOCRINOLOGY; HYPERCOAGULABILITY;

ADULT; AGED; AGED, 80 AND OVER; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; TESTOSTERONE; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 84896880734     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613499819     Document Type: Article

References (37)

1. Glueck CJ, Goldenberg N, Budhani S, et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res. 2011; 158 (4). 225-234
2. Glueck CJ, Freiberg RA, Wang P. Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res. 2008; 466 (5). 1034-1040
3. Glueck CJ, Freiberg RA, Boriel G, et al Clin Appl Thromb Hemost. 2012:
4. Glueck CJ, Richardson-Royer C, Schultz R, et al Clin Appl Thromb Hemost. 2013:
5. Glueck CJ, Richardson-Royer C, Schultz R, et al Clin Appl Thromb Hemost. 2013:
6. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002; 5 (2). 98-102
7. Cherrier MM, Matsumoto AM, Amory JK, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005; 64 (2). 290-296
8. Jankowska EA, Rozentryt P, Ponikowska B, et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009; 301 (18). 1892-1901
9. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CP. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab. 2006; 291 (3). E631-E638
10. Balasa VV, Gruppo RA, Glueck CJ, et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004; 86-A (12). 2642-2647
11. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999; 81 (5). 739-744
12. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost. 2005; 11 (4). 375-389
13. Glueck CJ, Pranikoff J, Aregawi D, et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism. 2005; 54 (10). 1345-1349
14. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism. 1993; 42 (2). 236-246
15. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001; 386: 19-33
16. Gonzales GF. Ethnobiology and ethnopharmacology of lepidium meyenii (Maca), a plant from the peruvian highlands. Evid Based Complement Alternat Med. 2012; 193496: 2012
17. Gonzales GF, Cordova A, Vega K, Chung A, Villena A, Gonez C. Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J Endocrinol. 2003; 176 (1). 163-168
18. Grifoni E, Marcucci R, Ciuti G, et al. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. Semin Thromb Hemost. 2012; 38 (2). 230-234
19. Okumus G, Kiyan E, Arseven O, et al. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost. 2008; 14 (2). 168-173
20. Svartberg J, Braekkan SK, Laughlin GA, Hansen JB. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. Eur J Endocrinol. 2009; 160 (5). 833-838
21. Liljeqvist S, Hellden A, Bergman U, Soderberg M. Pulmonary embolism associated with the use of anabolic steroids. Eur J Intern Med. 2008; 19 (3). 214-215
22. Sahraian MA, Mottamedi M, Azimi AR, Moghimi B. Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report. BMC Neurol. 2004; 4 (1). 22
23. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997; 277 (16). 1305-1307
24. Middeldorp S. Is thrombophilia testing useful?. Hematology Am Soc Hematol Educ Program. 2011; 2011 (1). 150-155
25. Roldan V, Lecumberri R, Munoz-Torrero JF, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res. 2009; 124 (2). 174-177
26. Kvasnicka J, Hajkova J, Bobcikova P, et al. Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)[in Czech]. Cas Lek Cesk. 2012; 151 (2). 76-82
27. Gabriel F, Portoles O, Labios M, et al. Usefulness of thrombophilia testing in venous thromboembolic disease: findings from the RIETE registry. Clin Appl Thromb Hemost. 2013; 19 (1). 42-47
28. Anawalt BD. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab. 2010; 95 (6). 2614-2617
29. Vitry AI, Mintzes B. Disease mongering and low testosterone in men: the tale of two regulatory failures. Med J Aust. 2012; 196 (10). 619-621
30. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010; 363 (2). 109-122
31. Shane R. Risk evaluation and mitigation strategies: impact on patients, health care providers, and health systems. Am J Health Syst Pharm. 2009; 66 (24 suppl 7). S6-S12
32. Glueck CJ, Bowe D, Valdez A, Wang P. Thrombosis in three post-menopausal women receiving testosterone therapy for low libido. Womens Health (Lond Engl). 2013; 9 (4). 405-410
33. Yao S, Till C, Kristal AR, et al. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control. 2011; 22 (8). 1121-1131
34. Amory JK, Wang C, Swerdloff RS, et al. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab. 2007; 92 (5). 1659-1665
35. Handelsman DJ, Goebel C, Idan A, Jimenez M, Trout G, Kazlauskas R. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men. Clin Endocrinol (Oxf). 2009; 71 (3). 417-428
36. Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med. 2010; 7 (1 pt 1). 269-276
37. Shabsigh A, Kang Y, Shabsign R, et al. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med. 2005; 2 (5). 716-721